ID: ALA4559219

Max Phase: Preclinical

Molecular Formula: C24H16F6N4O4

Molecular Weight: 538.40

Molecule Type: Unknown

Associated Items:

Representations

Canonical SMILES:  COC(=O)c1ccc2nc(Nc3ccc(OC(F)(F)F)cc3)c(Nc3ccc(OC(F)(F)F)cc3)nc2c1

Standard InChI:  InChI=1S/C24H16F6N4O4/c1-36-22(35)13-2-11-18-19(12-13)34-21(32-15-5-9-17(10-6-15)38-24(28,29)30)20(33-18)31-14-3-7-16(8-4-14)37-23(25,26)27/h2-12H,1H3,(H,31,33)(H,32,34)

Standard InChI Key:  ALAZXAMXAFIPFC-UHFFFAOYSA-N

Associated Targets(Human)

NCI-H1703 410 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

NCI-H226 44470 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

A549 127892 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

NCI-H358 882 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 538.40Molecular Weight (Monoisotopic): 538.1076AlogP: 6.70#Rotatable Bonds: 7
Polar Surface Area: 94.60Molecular Species: NEUTRALHBA: 8HBD: 2
#RO5 Violations: 2HBA (Lipinski): 8HBD (Lipinski): 2#RO5 Violations (Lipinski): 2
CX Acidic pKa: CX Basic pKa: 1.49CX LogP: 8.23CX LogD: 8.23
Aromatic Rings: 4Heavy Atoms: 38QED Weighted: 0.20Np Likeness Score: -0.87

References

1.  (2017)  Aryl amine substituted quinoxaline used as anticancer drugs, 

Source